Pharma Focus Europe
ThermoFisher Scientific - Custom and Bulks

Press Releases

Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients

Friday, April 19, 2024

BioPath Holdings Inc a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio

EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research

Friday, April 19, 2024

EditCo Bio Inc a pioneer at the forefront of genome engineering innovation today announced the launch of its Knockout CD Tcell Pools This latest addition to EditCo Bios product lineup marks a significant leap forward in CRISPRmediated

Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments

Friday, April 19, 2024

Evotec SE and Variant Bio Inc today announced a collaboration agreement to identify a bestinclass treatment for diseases caused by fibrosis Fibrosis is characterized by marked and pathogenic buildup

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)

Friday, April 19, 2024

Moleculin Biotech Inc a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hardtotreat tumors and viruses today

Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease

Thursday, April 18, 2024

Sage Therapeutics Inc announced today topline results from PRECEDENT a doubleblind placebocontrolled

IGM Biosciences Announces Refocusing of Sanofi Collaboration

Thursday, April 18, 2024

IGM Biosciences Inc a clinicalstage biotechnology company creating and developing engineered IgM antibodies today announced that the Companys exclusive worldwide collaboration agreement

Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases

Wednesday, April 17, 2024

Cullinan Therapeutics Inc formerly Cullinan Oncology Inc a biopharmaceutical company focused on developing modalityagnostic targeted therapies today announced important updates

Ose Immunotherapeutics Announces the Entry Into Force of the Global License to Develop an Innovative Monoclonal Antibody in the Treatment of Chronic Inflammation

Wednesday, April 17, 2024

OSE Immunotherapeutics SA a clinicalstage immunotherapies company announces the end of the waiting period provided for by the HartScott law Rodino

Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain

Tuesday, April 16, 2024

Sentynl Therapeutics Inc a USbased biopharmaceutical company whollyowned by Zydus Lifesciences Ltd today announced The Medicines and Healthcare products

magazine-slider-img
Get instant
access to our latest e-book
patheon - Mastering API production at every scaleLab Indonesia 20247th Pharma Packaging and Labelling Forum 2024Future Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Sartorius Webinar - Pave Your Weigh to Accurate Analytical ResultsEUROPEAN PHARMA OUTSOURCING SUMMIT 2024patheon - Revolutionizing PharmaWorld Vaccine Congress Europe 2024